raloxifene hydrochloride has been researched along with Carcinoma, Renal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y; Ma, Y; Wang, X; Ye, B; Zheng, Y | 1 |
1 other study(ies) available for raloxifene hydrochloride and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.
Topics: Antineoplastic Agents; Binding Sites; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavin-Adenine Dinucleotide; Histone Demethylases; Humans; Kidney Neoplasms; Molecular Docking Simulation; Raloxifene Hydrochloride | 2021 |